+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Limbal Stem Cell"

Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) - Forecast to 2029 - Product Thumbnail Image

Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) - Forecast to 2029

  • Report
  • June 2024
  • 295 Pages
  • Global
From
Limbal Stem Cells Deficiency (lsd) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Limbal Stem Cells Deficiency (lsd) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Limbal Stem Cell Deficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Limbal Stem Cell Deficiency - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 90 Pages
  • Global
From
Limbal Stem Cells Deficiency (LSD) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Limbal Stem Cells Deficiency (LSD) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Global Regenerative Medicine Market Analysis & Forecast to 2025; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - Product Thumbnail Image

Global Regenerative Medicine Market Analysis & Forecast to 2025; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • Report
  • September 2020
  • 700 Pages
  • Global
From
Applications of Flow Cytometry in Stem Cell Research and Tissue Regeneration. Edition No. 1 - Product Thumbnail Image

Applications of Flow Cytometry in Stem Cell Research and Tissue Regeneration. Edition No. 1

  • Book
  • September 2010
  • 418 Pages
  • 6 Results (Page 1 of 1)
Loading Indicator

The Limbal Stem Cell (LSC) market is a subset of the larger stem cell market. LSCs are a type of stem cell found in the cornea of the eye, and are used to treat a variety of eye diseases, such as corneal blindness, limbal stem cell deficiency, and ocular surface diseases. LSCs are harvested from donor tissue, and then cultured and expanded in the laboratory. The resulting cells are then transplanted into the patient's eye to restore vision. The LSC market is growing rapidly, driven by increasing demand for treatments for eye diseases, as well as advances in stem cell technology. The market is expected to continue to grow in the coming years, as more treatments become available and the technology continues to improve. Some of the major players in the LSC market include Advanced Cell Technology, BioTime, Cell Cure Neurosciences, CornealGen, and Ocata Therapeutics. Show Less Read more